Shares of Moderna Inc. MRNA slipped 2.31% to $41.83 Friday, on what proved to be an all-around mixed trading session for the ...

Two days after the FDA revealed that it had halted enrollment in trials of respiratory syncytial virus (RSV) vaccines that ...

Following news of RSV lower respiratory tract infections in infants immunized with Moderna’s investigational RNA vaccines, ...

Moderna Inc. closed $127.65 below its 52-week high ($170.47), which the company achieved on May 24th.

Norovirus vaccines face significant hurdles, with virtually no success from past efforts from HilleVax and Vaxxart. But ...

In the chaotic early days of the pandemic, Wall Street scrambled to place bets on the companies that looked the most likely ...

A Nasdaq-100 index membership means mutual funds, exchange-traded funds (ETFs), and other financial products based on this ...

If you want to stay updated on the latest options trades for Moderna, Benzinga Pro gives you real-time options trades alerts.

Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 10.82% ...

Palantir, MicroStrategy, and Axon Enterprise are set to join the Nasdaq 100 Index on Monday, Dec. 23, replacing Super Micro ...

Army National Guard Specialist Karoline Stancik suffered three heart attacks and a stroke after receiving the Moderna ...